BioCentury
ARTICLE | Top Story

Bloody Tuesday for biotech

December 24, 2014 2:52 AM UTC

Biotech shares dropped in the wake of Monday's news of price wars for HCV drugs, with the BioCentury 100 index falling 5% and the NYSE Arca Biotechnology (BTK) dropping 4%.

The BioCentury benchmark has fallen 6% since last Friday. The BTK, which hit a 52-week high last Friday, is off 5% on the week to 3,352. It has dropped 5-7% twice so far in December, but has not breached a floor of about 3,250. ...